Form 8-K - Current report:
SEC Accession No. 0001906324-24-000051
Filing Date
2024-11-08
Accepted
2024-11-08 11:17:19
Documents
14
Period of Report
2024-11-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20241107.htm   iXBRL 8-K 27215
  Complete submission text file 0001906324-24-000051.txt   179162

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20241107.xsd EX-101.SCH 2145
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20241107_def.xml EX-101.DEF 14443
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20241107_lab.xml EX-101.LAB 25398
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20241107_pre.xml EX-101.PRE 15018
16 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20241107_htm.xml XML 2704
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 241438759
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)